Trial intelligence / Profile preview

Povidone iodine concentration and exposure time before cataract surgery

ChiCTR1800018591Phase 4Completed

Sponsor
Hebei General Hospital
Start
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of povidone-iodine in cataract (3 arms), sponsored by Hebei General Hospital. Primary endpoints: Break-up time, Corneal fluorescein staining and 2 more. Started Jun 2016; status: completed.

02

Drugs

povidone-iodine
03

Conditions

cataract

Beyond the preview

Go deeper on ChiCTR1800018591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800018591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call